Check Credit Score

Check Credit Score

you are here: HomeNewsBusinessStocks

HOME

business

Alzheimer drug nod won't impact Lupin, Glenmark: Expert

Surajit Pal, analyst, Prabhudas Lilladher continues to have a positive outlook on Glenmark with a target price of Rs 1186 per share.

first published: Apr 15, 2015 09:09 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Arvind Kejriwal & K Kavitha's Judicial Custody Extended | Tihar Officials Gave Insulin To Kejriwal
Smriti Irani lashes out at Rahul Gandhi over ‘Khata Khat Gareebi Hta Denge’ remark in Amethi
Naseem Bano, Chikankari Practitioner & Padma Shri Awardee, Shared A Special Moment With PM Modi
Elon Musk's India strategy is on track | India visit postponed to later this year

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347